nilvadipine has been researched along with Debility in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meulenbroek, O | 1 |
| O'Dwyer, S | 1 |
| de Jong, D | 1 |
| van Spijker, G | 1 |
| Kennelly, S | 1 |
| Cregg, F | 1 |
| Olde Rikkert, M | 1 |
| Abdullah, L | 1 |
| Wallin, A | 1 |
| Walsh, C | 1 |
| Coen, R | 1 |
| Kenny, RA | 1 |
| Daly, L | 1 |
| Segurado, R | 1 |
| Borjesson-Hanson, A | 1 |
| Crawford, F | 1 |
| Mullan, M | 1 |
| Lucca, U | 1 |
| Banzi, R | 1 |
| Pasquier, F | 1 |
| Breuilh, L | 1 |
| Riepe, M | 1 |
| Kalman, J | 1 |
| Molloy, W | 1 |
| Tsolaki, M | 1 |
| Howard, R | 1 |
| Adams, J | 1 |
| Gaynor, S | 1 |
| Lawlor, B | 1 |
1 trial available for nilvadipine and Debility
| Article | Year |
|---|---|
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flo
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E3; Biomarkers; Calcium Channel Blockers; | 2016 |